Black Rock Inc. Blueprint Medicines Corp Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Black Rock Inc. holds 6,647,297 shares of BPMC stock, worth $670 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,647,297
Previous 6,447,461
3.1%
Holding current value
$670 Million
Previous $612 Million
17.14%
% of portfolio
0.02%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding BPMC
# of Institutions
342Shares Held
62.1MCall Options Held
987KPut Options Held
578K-
Vanguard Group Inc Valley Forge, PA6.54MShares$659 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$592 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$326 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$248 Million8.22% of portfolio
-
State Street Corp Boston, MA2.38MShares$240 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.02B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...